During the past grant cycle, the Masonic Cancer Center (MCC) used developmental funds to support the following activities: ? 13 newly recruited investigators ? Pilot Projects: several MCC pilot mechanisms provide funding to aid in the development of multi-investigator research.
The aim i s to develop competitive applications to submit to the National Cancer Institute's Specialized Programs of Research Excellence (SPOREs), Program Project (P01), or similar grant programs ? Clinical Pharmacology Developing Shared Resource, which has become an established shared resource in this submission ? Translational Methodologies support enabled Dr. Gunda Georg, Director of the Institute for Therapeutics Discovery &Development, to generate a triptolide derivative (termed Minnelide) and to optimize its pharmacokinetic properties for use as a cancer therapeutic. Recent work demonstrated the efficacy of this drug in vivo. Minnelide has been licensed to Minneamrita Therapeutics LLC for production and will be in a clinical phase I trial in the first half of 2013 The MCC is proposing to use developmental funds for the following purposes in the upcoming funding period: ? Newly recruited faculty ? Pilot research ? Two developing shared resources o Recruitment and Retention: This shared resource will support investigators in developing recruitment plans for therapeutic and non-therapeutic studies and ensuring complete and timely enrollment of participants. o Genome Engineering: This shared resource will use recombinant adeno-associated virus (rAAV) and transcription activator-like effector nucleases (TALENs) to make site-specific alterations in human cell lines ofthe investigator's choosing. ? Staff Investigator: We are requesting funding for a 10% time Research Staff Investigator who will be responsible for developing the Cancer Detection, Treatment, and Survivorship (CaDeTS) component of the Prevention and Etiology Program to address a range of issues relevant to cancer patients and their families, including early detection through screening programs, comparative effectiveness and quality of cancer care across the continuum of care, and long-term quality-of-life outcomes of cancer survivors

National Institute of Health (NIH)
National Cancer Institute (NCI)
Center Core Grants (P30)
Project #
Application #
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Minnesota Twin Cities
United States
Zip Code
Diep, Caroline H; Knutson, Todd P; Lange, Carol A (2016) Active FOXO1 Is a Key Determinant of Isoform-Specific Progesterone Receptor Transactivation and Senescence Programming. Mol Cancer Res 14:141-62
Yun, Young Sung; Kim, Kwan Hyun; Tschida, Barbara et al. (2016) mTORC1 Coordinates Protein Synthesis and Immunoproteasome Formation via PRAS40 to Prevent Accumulation of Protein Stress. Mol Cell 61:625-39
Yan, Y; Hanse, E A; Stedman, K et al. (2016) Transcription factor C/EBP-β induces tumor-suppressor phosphatase PHLPP2 through repression of the miR-17-92 cluster in differentiating AML cells. Cell Death Differ 23:1232-42
Sarver, Aaron L; Murray, Collin D; Temiz, Nuri A et al. (2016) MYC and PVT1 synergize to regulate RSPO1 levels in breast cancer. Cell Cycle 15:881-5
Than, B L N; Linnekamp, J F; Starr, T K et al. (2016) CFTR is a tumor suppressor gene in murine and human intestinal cancer. Oncogene 35:4179-87
Struntz, Nicholas B; Harki, Daniel A (2016) Catch and Release DNA Decoys: Capture and Photochemical Dissociation of NF-κB Transcription Factors. ACS Chem Biol 11:1631-8
Knorr, David A; Wang, Hongbo; Aurora, Mukta et al. (2016) Loss of T Follicular Helper Cells in the Peripheral Blood of Patients with Chronic Graft-versus-Host Disease. Biol Blood Marrow Transplant 22:825-33
Beura, Lalit K; Hamilton, Sara E; Bi, Kevin et al. (2016) Normalizing the environment recapitulates adult human immune traits in laboratory mice. Nature 532:512-6
Felices, Martin; Lenvik, Todd R; Davis, Zachary B et al. (2016) Generation of BiKEs and TriKEs to Improve NK Cell-Mediated Targeting of Tumor Cells. Methods Mol Biol 1441:333-46
Guo, Jingshu; Yun, Byeong Hwa; Upadhyaya, Pramod et al. (2016) Multiclass Carcinogenic DNA Adduct Quantification in Formalin-Fixed Paraffin-Embedded Tissues by Ultraperformance Liquid Chromatography-Tandem Mass Spectrometry. Anal Chem 88:4780-7

Showing the most recent 10 out of 763 publications